A TP-sensitive K ϩ (K ATP ) channels are nucleotide-gated bioenergy sensors that enable high-fidelity feedback communication between cellular energy dynamics and membrane electric activity. [1] [2] [3] [4] Particularly dense in cardiac sarcolemma where they are composed through heteromultimeric assembly of inwardly rectifying K ϩ channel pores, typically KCNJ11-encoded Kir6.2 proteins, and regulatory ATPbinding cassette (ABC) proteins, namely ABCC9-encoded SUR2A subunits, K ATP channels are increasingly recognized as integral to tissue energy conservation and optimization of energy use. 5 Integrated with intracellular energy pathways, sarcolemmal K ATP channels are established cardioprotectors implicated in the sustenance of wellness. 6 -8 Knockout of the Kir6.2 K ATP channel pore induces inefficient cardiac energetics associated with altered metabolic fuel selection and remodeling of the myocardial proteome, highlighting a distinct role of the channel in heart energy homeostasis. 9,10 K ATP channel ablation alters the expression of one tenth of largely metabolism-related protein species, exposing within the K ATP channel-deficient ventricle markers of cardiovascular disease susceptibility. 9, 11 Indeed, disruption of the Kir6.2 K ATP channel compromises cardiac protection afforded by ischemic preconditioning, impairs myocardial tolerance to sympathetic surge, and aggravates the impact of endurance challenge or hemodynamic overload precipitating heart failure under stress. 12 Conversely, overexpression of channel subunits generates a protective phenotype at cellular and organ levels. 13, 14 High-throughput molecular technologies applied to phenotypically characterized patient and population cohorts have contributed to the deciphering of human K ATP channelopathies, disease entities caused by genetic disruption of ion channel function. [15] [16] [17] [18] [19] In cardiovascular medicine, mutations in the regulatory SUR2A subunit have been linked to K ATP channelopathy-associated electric and cardiomyopathic disorders, namely the syndromes of adrenergic atrial fibrillation and dilated cardiomyopathy with tachycardia. 19 -21 Moreover, in clinical heart failure, a common polymorphism in the Kir6.2 K ATP channel pore subunit has been identified as a robust biomarker for impaired performance in stress test. 22 Furthermore, the Kir6.2 K23 allele, present in more than half of the population, has been pinpointed as an independent risk factor for susceptibility to maladaptive cardiac remodeling in hypertension. 23 Cardiovascular disorders associated with genetic variation in K ATP channel genes also include myocardial infarction and ventricular fibrillation. Collectively, advances in molecular medicine have enabled a growing understanding of genetically determined channel function and malfunction, underscoring the broadening awareness of the impact of the K ATP channel complex on individual and public cardiovascular health.
K ATP Channel Complexes: Nucleotide-Gated Heteromultimers
K ATP channels originally were identified in the plasma membrane of cardiomyocytes 24 and shortly thereafter in other metabolically active tissues, such as pancreatic ␤-cells, and in subcellular compartments, including mitochondria. 2, 4, 25, 26 Plasmalemmal K ATP channels, the focus of this overview, are compulsory heteromultimers formed by octameric assembly of inward-rectifier K ϩ channels (Kir6.1, Kir6.2) with ABC proteins (SUR1, SUR2A, SUR2B). [27] [28] [29] [30] [31] [32] Human Kir6.1 and Kir6.2 genes KCNJ8 and KCNJ11 map to chromosome 12p11.23 and 11p15.1 and comprise 2 and 1 coding exons, respectively. Sulfonylurea receptor genes SUR1 (or ABCC8) at locus 11p15.1 and SUR2 (or ABBC9) at locus 12p12.1 comprise 39 and 38 exons, respectively ( Figure 1 ). Alternative splicing gives rise to SUR2 protein variants SUR2A and SUR2B. Tissue diversity, cellular distribution, and regulatory specificity are ensured by an assortment of subunit and isoform combinations. Biophysical properties are largely shared among plasmalemmal K ATP channels and include potassium selectivity and inward rectification imparted by the Kir protein, whereas responsiveness to cellular energetic signals is conferred by nucleotide interaction with both Kir and SUR channel subunits. 33 Kir6.2 is integral in the make-up of myocellular K ATP channels, and targeted disruption of KCNJ11 generates a Kir6.2-deficient state characterized by lack of functional K ATP channels in ventricular myocytes. 34 Sarcolemmal K ATP channels in the ventricle are composed primarily through coassembly of Kir6.2 and SUR2A subunits ( Figure 1 ). Indeed, recombinant Kir6.2/SUR2A channels match features of native ventricular myocyte K ATP channels. 35 The molecular channel architecture, however, may exhibit plasticity, particularly in response to metabolic challenge. Kir6.1 mRNA expression, for example, is significantly elevated after ischemia or hypoxia, raising the possibility that Kir6.1 may be upregulated in myocytes in response to stress. 36 Moreover, a disparate structure of atrial compared to ventricular K ATP channels has been proposed, implicating SUR1-based channels in atrial-specific functions, such as coupling atrial stretch with secretion of the atrial natriuretic peptide. 37, 38 Crosstalk of cardiac K ATP channel proteins with myocellular energetics is facilitated by privileged associations of channel subunits with phosphotransfer and glycolytic enzymes. 39 Metabolism-related proteins with established links to the cardiac K ATP channel include creatine kinase, adenylate kinase, glyceraldehyde-3-phosphate dehydrogenase, lactate dehydrogenase, long-chain acyl-coenzyme A dehydrogenase, pyruvate kinase, and triosephosphate isomerase. 40 -45 More broadly, Ͼ100 K ATP channel-dependent proteins have been identified through deconvolution of the K ATP channel knockout heart proteome. 8 -10 Categorization of proteomic changes in the K ATP channel-deficient myocardium has demonstrated a highly represented metabolic theme that includes members of the tricarboxylic acid cycle, fatty acid ␤-oxidation, glycolysis, and amino acid and nucleic acid metabolism. 8 -10 ATP/ADP modulation of channel function is a defining property of K ATP channels as metabolic sensors ( Figure  1 ). 5, 8, 33, 46 The interface between Kir6.2 subunits is critical for ATP-mediated pore inhibition. 47 Nucleotide-binding domains NBD1 and NBD2 of SUR2A harbor intrinsic ATPase activity, endowing this regulatory K ATP channel subunit with the ability to modulate ATP-induced Kir6.2 pore inhibition and, thereby, K ϩ efflux to reduce myocyte excitability. 48 -52 It is believed that by relying on the intactness of cooperative NBD1/2 interaction, a stabilized ADP-bound posthydrolytic conformation at NBD2 of SUR in the presence of Mg 2ϩ , promotes K ATP channel opening. 1, [53] [54] [55] Furthermore, the nucleotide-bound conformations of SUR mediate the regulation of K ATP channel activity by pharmacological agents, such as sulfonylurea inhibitors and potassium channel openers (KCO). 33, 55 
K ATP Channels: Stress Without Distress
Vital in the adaptive response to metabolic stress, cardioprotective K ATP channels comprise a recognized energy-sparing system that limits muscle energy expenses during the propagation of action potentials. 7, 8, 33, 56 Defined as the most densely expressed K ϩ channels in the myocardium, K ATP channels are critical endogenous elements for cardiac energy homeostasis and electric stability across a spectrum of stress conditions, including acute ischemia, the fight-or-flight response, chronic exertion, and heart failure. 12, 19, 57 
Ischemic Stress
In ischemia, K ATP channel opening shortens the duration of cardiac action potential ( Figure 1 ) and controls Ca 2ϩ influx. 58, 59 Sarcolemmal K ATP channel activation is apparently responsible for the electric current that underlies ST-segment elevation of transmural ischemic injury and has been implicated in protection afforded by ischemic preconditioning. 12 Figure 1 . Structure and function of ventricular sarcolemmal K ATP channel complexes. The pore-forming KCNJ11encoded Kir6.2 subunit assembles with the regulatory ABCC9-encoded SUR2A protein to form heteromultimeric K ATP channels abundantly expressed in the ventricular sarcolemma. The defining feature of K ATP channel operation is adenine nucleotide-dependent gating, ensuring high-fidelity coupling between the cellular energetic state and the membrane electric activity. Intracellular ATP keeps K ATP channels closed under normal conditions, whereas ADP promotes channel opening in response to metabolic challenge. K ATP channel opening under stress translates into shortening of the cardiac action potential (2APD) and accelerated repolarization. K ATP indicates ATP-sensitive K ϩ .
Ablation of K ATP channels disrupts the homeostatic mechanism integral to energetic myocardial stability under ischemic stress. Specifically, in the Kir6.2-knockout mouse after transmural anterior myocardial infarction, absence of significant and sustained ST-segment change has been documented and contrasts the wild-type counterpart that demonstrates prompt and pronounced ST-segment elevation after ischemic injury. 60 K ATP channel activity in ischemia appears to have a clinically significant diagnostic implication. In particular, patients with diabetes mellitus presenting with acute myocardial infarction demonstrate attenuated ST-segment elevation when taking sulfonylureas, inhibitors of K ATP channel activity, resulting in a failure to meet criteria for emergent revascularization therapy and, as a consequence, inappropriate withholding of proven beneficial therapy. 12 Moreover, K ATP channels have been implicated in the ischemic preconditioning mechanism by which exposure to brief ischemia preceding a sustained ischemic insult reduces subsequent infarct size. 61 Analogous to ischemic preconditioning, pharmacological activation of the channel by K ATP channel openers also has protective benefit. 62, 63 Both ischemic and pharmacological preconditioning are abolished in the absence of Kir6.2-containing K ATP channels. 64, 65 Absence of sarcolemmal K ATP channel activity has negative effects on cardiac relaxation and contractility under acute ischemic stress. In parallel, knockout of Kir6.2 negates protection afforded by ischemic preconditioning on myocardial energy generation, transfer, and use. 66 Total ATP turnover, a global parameter of energy demand, fails to increase in the ischemic-preconditioned K ATP channel knockout as opposed to the wild type, correlating with failure of preconditioned hearts lacking K ATP channels to functionally recover. 66 The K ATP channel-dependent cardioprotective potential is underscored by improved myocardial function during postischemic reperfusion after introduction of the SUR2A transgene into the SUR2 null cardiomyocyte. 67
Fight-or-Flight Response
Beyond protection against the insult of ischemia, K ATP channels serve as guarantors of metabolic and ionic homeostasis, appearing central to cardiac participation in the general adaptation syndrome. 57 In the fight-or-flight response, metabolic adaptations in bodily functions achieve a superior level of performance necessary to cope with the demands of imposed stress. The sustenance of augmented performance requires energy-controlling mechanisms, such as the K ATP channel, ensuring that the reaction to stress itself does not become harmful, that is, "stress without distress." 57 A common trigger of the general adaptation syndrome is systemic sympathetic stimulation that augments cardiac contractility and heart rate and, thereby, provides the necessary higher cardiac output to meet demand. Enhanced cardiac output imposes a significant metabolic load on the heart. A compensatory increase in outward K ϩ current activates when the sustained augmentation of heart muscle performance competes with the ability of cellular energetics to maintain contractile and electric stability. The K ATP channel-mediated action potential shortening limits actomyosin ATP consumption by reducing Ca 2ϩ influx, thereby restraining energy use to ensure functional and structural cellular integrity. 68 Under sympathetic distress, hearts without K ATP channels lack stress-induced cardiac action potential shortening predisposing to cytosolic Ca 2ϩ overload associated with development of contractile dysfunction and possibly death. 68 On autopsy, contraction bands, pathognomonic of cytosolic Ca 2ϩ loading, are visible throughout the myocardium of the Kir6.2 knockout but not wild type. 68 Measurement of oxygen consumption reveals that increased workloads produce only moderate elevation of energy expenditure in line with K ATP channeldependent shortening of action potential duration. 56 Conversely, absence of K ATP channel-driven action potential shortening in K ATP channel-deficient hearts precipitates significant elevation in oxygen consumption. 56 Under catecholamine challenge, action potential prolongation remains uncompensated in the absence of K ATP channel function, predisposing the myocardium to early afterdepolarizations. 69 This deficit in repolarization reserve translates into a high risk for induction of triggered activity and ventricular dysrhythmia. 69 Intact K ATP channel function thus appears mandatory for adequate repolarization under sympathetic stress, providing electric tolerance against triggered arrhythmia. Proarrhythmogenic features and lack of adaptation to stress in transgenic mice with cardiac myocyte-specific ablation of K ATP channels verifies that these features are intrinsic to the myocardium and that K ATP channel function plays an essential role in protecting the heart from lethal arrhythmias, ensuring stress adaptation. 70 Moreover K ATP channels may provide a vital feedback element for cardiovascular tolerance in sepsis, where the systemic inflammatory response to infection imposes a high demand for bodily adaptation. 71 In a model of acute septic shock induced by endotoxin lipopolysaccharide challenge, knockout of the KCNJ8 gene encoding the typically vascular Kir6.1 K ATP channel pore predisposes to an early and profound survival disadvantage. The exaggerated susceptibility provoked by disruption of Kir6.1containing channels was linked to progressive deterioration in cardiac activity, ischemic myocardial damage, and contractile dysfunction. 71 Harnessing the ability to recognize alterations in the cellular energy state and to translate this information into changes in membrane excitability, K ATP channels therefore provide a link necessary for maintaining myocardial well-being in the face of stress-induced energy demanding augmentation in performance.
Chronic Exertion
Exercise training elicits an array of metabolic responses that underlie fitness. Mice lacking K ATP channels when challenged with a regimented training protocol failed to manifest improved exercise capacity. 72 Repetitive exercise stress unmasks a survival disadvantage in the Kir6.2 knockout associated with cardiac damage, implicating K ATP channel activity in achieving physiological benefits of exercise training without accumulating deficits. 72 Even modest stress after a repetitive physical exertion program provokes significant mortality in the Kir6.2 knockout, with death occurring during or suddenly in the immediate postexercise period, 72 perhaps representing manifestation of stress-induced dysrhythmia to which Kir6.2 knockout mice are predisposed. 69, 70 Exercise intolerance also has been documented in the setting of ablation of the regulatory SUR2 subunit, 73 underscoring the role of K ATP channels in ensuring optimal performance. Beyond physical exercise, in distinct hyperadrenergic states exemplified by cocaine abuse, K ATP channel deletion amplifies poor cardiovascular outcome, whereas promotion of channel activity by potassium channel opening drugs improves survival. 74, 75 
Experimental Heart Failure
Intact K ATP channels prevent the transition from a state of disease risk to that of overt organ failure. In experimental hypertension induced by volume overload, knockout of Kir6.2 K ATP channels predisposes to heart failure and death. 76 Defective decoding of hypertension-induced metabolic distress signals in the K ATP channel knockout sets in motion pathological Ca 2ϩ overload and aggravates cardiac remodeling through a calcium/calcineurin-dependent cyclosporinesensitive pathway, implicating intact channel activity as a required safety element that prevents hypertension-induced heart failure. 76 Similarly, in experimental models of pressure overload, such as that imposed by transverse aortic constriction, compromised K ATP channel function renders the heart vulnerable to poor outcome. 77 The constricted K ATP channel knockout displays fulminant biventricular congestive heart failure characterized by exercise intolerance, cardiac contractile dysfunction, hepatopulmonary congestion, and death. Surviving K ATP channel knockouts develop sequelae, including exaggerated fibrotic myocardial hypertrophy associated with nuclear upregulation of calcium-dependent proremodeling MEF2 and NF-AT pathways, precipitating chamber dilatation. 77 Moreover, it has been documented that diseaseinduced K ATP channel metabolic dysregulation, even in the absence of channel gene defect, is a contributor to the pathobiology of heart failure, illustrating a mechanism for acquired channelopathy. 78 Thus, operational K ATP channels appear mandatory in securing cardiac adaptation and protecting against heart failure. 12
Human Cardiac K ATP Channelopathies
Genetically determined K ATP channel malfunction originally has been linked to insulin secretory disorders, namely congenital hyperinsulinism and neonatal diabetes. 4, [17] [18] [19] 79, 80 Beyond isolated failure of pancreatic ␤-cells, K ATP channel mutations are pathogenic in the DEND syndrome characterized by varying degrees of delayed speech and motor development, epilepsy, neonatal diabetes, muscle hypotonia, and balance issues. [17] [18] [19] An even broader role in disease pathogenesis has been realized with the discovery of K ATP channel malfunction in human skeletal myopathies. 81, 82 In cardiovascular medicine, K ATP channelopathies have been associated with atrial fibrillation and dilated cardiomyopathy with tachycardia as well as with phenotypic modifiers of preclinical and overt heart disease ( Figure 2 ). 19
Adrenergic Atrial Fibrillation
Atrial fibrillation increasingly is recognized as having genetic underpinnings. 83, 84 A case in point is early onset attributable to monogenic defects in a subset of patients. The paradigm of a heritable basis for atrial fibrillation is exemplified by reports of familial disease attributed to gain-of-function or loss-of-function mutations in ion channel genes predicted to accelerate or slow repolarization. In these cases, channel malfunction creates an arrhythmogenic substrate of reentry or triggered activity caused by reduced electric refractoriness and afterdepolarization, respectively. Initially, channelopathy-based atrial fibrillation predicted shortening of the action potential duration and proarrhythmogenic reduction in refractory period as mechanisms of arrhythmia. 85, 86 An alternative mechanism for atrial fibrillation, namely increased propensity for prolongation of action potential duration and triggered activity in the human atrium, was identified for a loss-of-function mutation in KCNA5 encoding the voltage-dependent Kv1.5 channel. 87 A possibly equivalent mechanism has been reported in the case of a K ATP channel mutation conferring risk for adrenergic atrial fibrillation originating from the vein of Marshall. 20 The mutation was identified in a middle-aged patient who, in the absence of identifiable risk factors, presented with longstanding atrial fibrillation precipitated by activity and refractory to medical therapy. In this patient with early-onset atrial fibrillation and an overtly normal heart, adrenergic stress as a possible trigger was investigated using a candidate gene approach and invasive electrophysiological testing under sympathomimetic challenge. 20 The focal source of rapidly firing electric activity was mapped to the vein of Marshall, a remnant of the left-side superior vena cava rich in sympathetic fibers and a recognized source for adrenergic atrial fibrillation. Although this potentially arrhythmogenic venoatrial interface is present in the population at large, it does not trigger arrhythmia in the majority of individuals despite comparable environmental stress exposure. It was postulated that the patient was vulnerable to adrenergic atrial fibrillation due to an inherent defect in electric stability. 20 Molecular genetics investigation demonstrated a missense mutation in ABCC9 encoding the regulatory subunit of cardiac K ATP channels (Figure 2 ). 20 Identified in exon 38a, which is specific for the cardiac splice variant of SUR2A, this heterozygous c.4640CϾT transition caused substitution of the threonine residue at amino acid position 1547 with isoleucine (T1547I). Protein alignments revealed that the missense substitution altered the amino acid sequence of the evolutionarily conserved carboxy-terminal tail. Homology modeling mapped the defect adjacent to the signature Walker motifs of the nucleotide-binding domain required for coordination of adenine nucleotides in the nucleotide-binding pocket. Removal of the polar threonine (T1547) and replacement with the larger aliphatic and highly hydrophobic isoleucine, as would occur in this patient, predicts compromised nucleotide-dependent K ATP channel gating. 20 Patch-clamp recording demonstrated that the T1547I substitution compromised adenine nucleotide-dependent induction of K ATP channel current. 20 Mutant T1547I SUR2A, coexpressed with the KCNJ11-encoded Kir6.2 pore, generated an aberrant channel that retained ATP-induced inhibition of potassium current but demonstrated a blunted response to ADP. A deficit in nucleotide gating resulting from the T1547I mutation would compromise the homeostatic role of the K ATP channel required for proper readout of cellular distress and maintenance of electric stability.
The pathogenic link between channel malfunction and adrenergic atrial fibrillation in this patient was verified at the whole-organism level in a murine knockout model deprived of operational K ATP channels. Compared with the normal atrium, which is resistant to arrhythmia under adrenergic provocation, vulnerability to atrial fibrillation was recapitulated in the setting of a K ATP channel deficit. 20 Thus, a lack of intact K ATP channels due to either a naturally occurring mutation affecting channel regulation or a targeted disruption of the channel complex is a substrate for atrial electric instability under stress and a molecular risk factor for adrenergic atrial fibrillation.
Once the vein of Marshall had been isolated by radiofrequency ablation, atrial fibrillation no longer could be provoked by programmed electric stimulation and burst pacing with or without isoproterenol infusion. 20 This case demonstrates that vulnerability to arrhythmia can be caused by an inability of mutant K ATP channels to safeguard against adrenergic stress-induced ectopy. The apparently curative outcome was achieved by disrupting the gene-environment substrate for arrhythmia conferred by the underlying K ATP channelopathy. 19 
Risk Factor for Electric Instability
Although the case underscores heritable channel dysfunction in lone atrial fibrillation, 20 K ATP channel deficit could play a broader role in the pathogenesis of electric instability. Gene expression and electrophysiological studies in patients with atrial fibrillation demonstrate altered atrial ion channel mRNA transcription and posttranslational activity, including downregulation of the K ATP channel pore and associated current. 88, 89 Moreover, structural heart disease, atrial dilation, or both may compromise metabolic and mechanosensitive gating of K ATP channels, 90 -92 precipitating a suboptimal repolarization reserve and providing a substrate for the more common acquired form of atrial fibrillation.
K ATP channel alteration also may affect predisposition toward ventricular vulnerability to arrhythmia. In this regard, a case of ventricular fibrillation with prominent early repolarization recently was reported in a young patient who was resuscitated after an episode of sudden death. Subsequent, unrelenting ventricular fibrillation was unresponsive to several classes of antiarrhythmics before rhythm restoration with quinidine. 93 Myopathic and coronary heart disease were excluded, and a K ATP channel subunit amino acid substitution, namely the S422L variant of the KCNJ8 gene encoding Kir6.1, was identified (Figure 2 ). 93 The gain-of-function K ATP channel variant was further linked to the pathogenic substrate of pleiotropic J-wave abnormalities in single Brugada syndrome and early repolarization syndrome cases. 94
Dilated Cardiomyopathy With Tachycardia
Beyond isolated arrhythmias, K ATP channelopathy has been implicated in a syndrome of cardiomyopathy with ventricular arrhythmia. The ontological spectrum of cardiomyopathyassociated mutant gene products has encompassed the fundamental components of excitation-contraction coupling, such as contractile, cytoskeletal, and myocellular ion regulatory proteins. 95 Human molecular genetics studies also have linked K ATP channel defects and aberrant homeostatic stress response in the pathogenesis of dilated cardiomyopathy. 19 These defects identified in the regulatory K ATP channel subunit impair channel-dependent decoding of cellular metabolic state, establishing a previously unrecognized mechanism in human heart failure. 18 The cardiomyopathic-arrhythmia syndrome characterized by the triad of dilated cardiomyopathy, ventricular arrhythmia, and ABCC9 K ATP channel mutations has been designated as CMD1O (Online Mendelian Inheritance in Man #608569) (Figure 2 ), 21 and salient phenotypic traits were reproduced by K ATP channel knockout under imposed stress. 77 Clinically, this entity was reported in middle-aged patients with marked left ventricular enlargement, severe systolic dysfunction, and ventricular tachycardia. In these patients, heterozygous mutations were identified in exon 38a of ABCC9, which encodes the C-terminal domain of the SUR2A channel subunit specific to the cardiac splice variant. DNA sequencing of a mutated allele identified a 3-bp deletion and 4-bp insertion mutation (c.4570 to 4572delTTAinsAAAT), causing a frameshift at L1524 and introducing 4 anomalous terminal residues followed by a premature stop codon (fs1524). 21 Another mutated allele harbored a missense mutation (c.4537GϾA) causing the amino acid substitution A1513T. The identified frameshift and missense mutations occurred in evolutionarily conserved domains of SUR2A, and neither mutation was present in unrelated control individuals. 21 The identified missense and frameshift mutations were mapped to domains bordering the catalytic ATPase pocket within SUR2A. Structural molecular dynamics simulation showed that residues A1513 and L1524 flank the C-terminal ␤-strand in proximity to the signature Walker A motif required for coordination of nucleotides in the catalytic pocket of ABC proteins. 21 Replacement of A1513 with a sterically larger and more hydrophilic threonine residue or truncation of the C-terminus caused by the fs1524 mutation would disrupt folding of the C-terminal ␤-strand and, thus, the tertiary organization of the adjacent second nucleotidebinding domain NBD2 pocket in SUR2A ( Figure 2 ). Indeed, ATP-induced K ATP channel gating was aberrant in channel mutants, suggesting that structural alterations induced by the mutations A1513T and fs1524 of SUR2A distorted ATPdependent pore regulation. 21 Thus, the mutations A1513T and fs1524 compromise ATP hydrolysis at SUR2A NBD2, generating distinct reaction kinetic defects. Aberrant catalytic properties in the A1513T and fs1524 mutants translated into abnormal interconversion of discrete conformations in the NBD2 ATPase cycle. Alterations in hydrolysis-driven SUR2A conformational probability induced by A1513T and fs1524 perturbed intrinsic catalytic properties of the SUR2A ATPase, compromising proper translation of cellular energetic signals into K ATP channel-mediated membrane electric events. Traditionally linked to defects in ligand interaction, subunit trafficking, or pore conductance, human cardiac K ATP channel dysfunction provoked by alterations in the catalytic module of the channel complex establishes a new mechanism for channelopathy.
Risk Factor for Cardiac Remodeling
Susceptibility or resistance to heart failure, despite apparently similar risk load, is attributable to individual variation in homeostatic reserve. After identification of mutations within a K ATP channel gene in patients with dilated cardiomyopathy, 21 the relationship between the common Kir6.2 E23K polymorphism (rs5219) and subclinical heart disease was investigated ( Figure 2 ). 23 A community-based cross-sectional cohort of 2031 predominantly white adults was used for whom detailed clinical and prospective echocardiographic data were available. Genotype frequencies were in Hardy-Weinberg equilibrium (EEϭ44%, EKϭ47%, KKϭ9%) and similar to previously reported control populations. In the group at large, there was no significant association between genotypes and measures of cardiac structure and function (left ventricular dimensions, mass, and ejection fraction), electric instability (atrial and ventricular arrhythmias), or metabolism (fasting glucose, diabetes, and body mass index) at enrollment. However, among individuals with documented hypertension at the time of echocardiography (nϭ1187), the KK genotype was significantly associated with greater left ventricular dimension and volume in both diastole and systole. 23 A synergistic effect on left ventricular size of KK genotype and left ventricular mass, a marker of chronic cardiac stress load, further validated the impact of Kir6.2 E23K on cardiac structure in hypertension. From a public health perspective, hypertension is the most common risk factor for congestive heart failure, and left ventricular enlargement is an established precursor of symptomatic ventricular dysfunction. The Kir6.2 K23 allele, present in more than half the population, thus is implicated as a risk factor for transition from hypertensive stress load to subclinical maladaptive cardiac remodeling. 23 These findings are consistent with previous human and animal studies 19, 76 and uncover an interactive K ATP channel gene-environment substrate that confers cardiac disease risk. Determining the overall impact of Kir6.2 E23K across ethnic groups and on long-term clinical outcome (ie, progression to left ventricular enlargement and clinical heart failure) will require further study.
Biomarker for Impaired Stress Performance
The translational significance of the Kir6.2 E23K polymorphism in human cardiac physiology was more recently explored in a cohort of patients with heart failure who underwent comprehensive exercise stress testing. 22 The frequency of the minor K23 allele was found to be overrepresented in the 115 subjects with congestive heart failure compared with the 2031 community-based controls described previously 23 (69% versus 56%, PϽ0.001). Moreover, the KK genotype, present in 18% of patients with heart failure, was associated with abnormal cardiopulmonary exercise stress test results. 22 Despite similar baseline heart rates at rest among genotypic subgroups, subjects with the KK genotype had a significantly reduced heart rate increase at matched workloads. Molecular modeling of the tetrameric Kir6.2 pore structure revealed the E23 residue within the functionally relevant intracellular slide helix region. 22 Substitution of the wild-type E residue with an oppositely charged, bulkier K residue would potentially result in a significant structural rearrangement and disrupted interactions with neighboring Kir6.2 subunits, providing a basis for altered high-fidelity K ATP channel gating, particularly in the homozygous state. Blunted heart rate response during exercise is a risk factor for mortality in patients with heart failure, establishing the clinical relevance of Kir6.2 E23K as a biomarker for impaired performance under exercise stress and underscoring the essential role of K ATP channels in human cardiac physiology. 22
Association With Myocardial Infarction
Experimental evidence also suggests that K ATP channels could be involved in the pathogenesis of coronary vasomotor dysfunction and ischemic heart disease. 96, 97 The potential clinical significance of such a premise was documented in a cohort of patients with myocardial infarction at an early age, whereby a rare missense variant, V734I, in the ABCC9 SUR2A K ATP channel gene was found to be overrepresented (Figure 2 ). 98 Statistical significance was demonstrated after controlling for multiple established risk factors for coronary artery disease. 98
Summary
Deficient cellular energetics set by aberrant K ATP channel function increasingly is implicated in a spectrum of conditions underlying metabolic imbalance and electric instability. 5 Indeed, cardiac K ATP channelopathies are emerging as a recognized disease entity underlying heart failure and arrhythmia. 19 Understanding the molecular structure and function of K ATP channel subunits, 8 and their relationship to cellular metabolic signaling, 99 has been instrumental in interpreting the pathophysiology of channel malfunction associated with heart disease predisposition ( Figure 3 ). 12 From individual patients to populations, variants in K ATP channel genes now have been documented in human dilated cardiomyopathy 21 and atrial fibrillation 20 and as risk factors for electric instability, 93, 94 adverse cardiac remodeling, 23 impaired performance under stress, 22 or myocardial infarction. 98 Beyond the initial deciphering of genotype-phenotype relationships, development and application of high-throughput platforms to screen for disrupted coding and regulatory sequences in cardioprotective K ATP channel genes as well as diagnosis of corrupted interactions within the cellular milieu would advance current knowledge regarding this homeostatic channel complex and its implications in cardiovascular medicine. In particular, deconvolution of altered metabolic pathways and signaling cascades associated with pathogenic K ATP channel mutation may offer unique opportunities to pinpoint lesions that stratify the consequences of genetic variation on disease traits. 18 In this regard, it can be anticipated that systems biology and network medicine strategies increasingly will be deployed to resolve the K ATP channel interactome. 11 Mapping of the systems integration of molecules and their respective biolog-ical networks in health versus disease will, in turn, guide the judicious development of prognostic discriminators of disease variability and selection of treatment response predictors. 100 -102 Advances in the molecular medicine of K ATP channelopathies thus are poised to offer new perspectives in the diagnosis and therapy of individuals and populations. [103] [104] [105] [106] [107] 
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